Engaging Members of African American and Latino Communities in Preventive H IV Vaccine TrialsSOBIESZCZYK, Magdalena E; GUOZHEN XU; GOODMAN, Krista et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 2, pp 194-201, issn 1525-4135, 8 p.Article

Using Social Networks to Recruit an HIV Vaccine Preparedness CohortVALENTE, Thomas W; ZOGG, Jennifer B; CHRISTENSEN, Shawna et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 4, pp 514-523, issn 1525-4135, 10 p.Article

Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with menQINGCHUN LI; FENGJI LUO; ZHENHAI ZHOU et al.Vaccine. 2010, Vol 28, Num 29, pp 4638-4643, issn 0264-410X, 6 p.Article

Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug usersDHALLA, Shayesta; POOLE, Gary; SINGER, Joel et al.Vaccine. 2010, Vol 28, Num 7, pp 1663-1667, issn 0264-410X, 5 p.Article

Theoretical model of critical issues in informed consent in HIV vaccine trialsLEWIS, Cindi A; DEWHURST, Stephen; MCMAHON, James M et al.AIDS Care (Print). 2014, Vol 26, Num 11-12, pp 1452-1460, issn 0954-0121, 9 p.Article

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of VaccinesKOFF, Wayne C; RUSSELL, Nina D; WALPORT, Mark et al.Vaccine. 2013, Vol 31, issn 0264-410X, B204-B208, SUP2Article

Vaccine-Induced HIV-Specific CD8+ T Cells Utilize Preferential HLA Alleles and Target-Specific Regions of HIV-1FRIEDRICH, David; JALBERT, Emilie; DINGES, Warren L et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 3, pp 248-252, issn 1525-4135, 5 p.Article

Preparing for the availability of a partially effective HIV vaccine: Some lessons from other licensed vaccinesCHEN, Robert T; HU, DaleJ; DUNNE, Eileen et al.Vaccine. 2011, Vol 29, Num 36, pp 6072-6078, issn 0264-410X, 7 p.Conference Paper

Selectively willing and conditionally able: HIV vaccine trial participation among women at high risk of HIV infectionVOYTEK, Chelsea D; JONES, Kevin T; METZGER, David S et al.Vaccine. 2011, Vol 29, Num 36, pp 6130-6135, issn 0264-410X, 6 p.Conference Paper

The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and ThailandANDERSSON, Kyeen M; STOVER, John.Vaccine. 2011, Vol 29, Num 36, pp 6092-6099, issn 0264-410X, 8 p.Conference Paper

The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: Examining the RV144 trial resultsANDERSSON, Kyeen M; DAVID PALTIEL, A; OWENS, Douglas K et al.Vaccine. 2011, Vol 29, Num 36, pp 6107-6112, issn 0264-410X, 6 p.Conference Paper

Design, Construction, and Characterization of a Multigenic Modified Vaccinia Ankara Candidate Vaccine Against Human Immunodeficiency Virus Type 1 Subtype C/B'ZHIWEI CHEN; YAOXING HUANG; XIUQING ZHAO et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 4, pp 412-421, issn 1525-4135, 10 p.Article

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersGOEPFERT, Paul A; TOMARAS, Georgia D; MCELRATH, M. Juliana et al.Vaccine. 2007, Vol 25, Num 3, pp 510-518, issn 0264-410X, 9 p.Article

A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studiesKROHN, Kai; STANESCU, Ioana; BLAZEVIC, Vesna et al.Microbes and infection. 2005, Vol 7, Num 14, pp 1405-1413, issn 1286-4579, 9 p.Article

Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virusLAKHASHE, Samir K; BYRAREDDY, Siddappa N; VARGAS-INCHAUSTEGUI, Diego A et al.Vaccine. 2014, Vol 32, Num 48, pp 6527-6536, issn 0264-410X, 10 p.Article

Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisitionNOVAK, Richard M; METCH, Barbara; SOBIESZYCZ, Magda et al.AIDS (London). 2013, Vol 27, Num 11, pp 1763-1770, issn 0269-9370, 8 p.Article

Successful vaccination of immune suppressed recipients using Listeria vector HIV-1 vaccines in helminth infected miceSHOLLENBERGER, Lisa M; BUI, Cac; PATERSON, Yvonne et al.Vaccine. 2013, Vol 31, Num 16, pp 2050-2056, issn 0264-410X, 7 p.Article

HIV vaccines: current status worldwide and in AfricaFAST, Patricia E; KALEEBU, Pontiano.AIDS (London). 2010, Vol 24, issn 0269-9370, S50-S60, SUP4Article

A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adultsXIA JIN; NEWMAN, Mark J; NOONAN, Elizabeth et al.Vaccine. 2009, Vol 27, Num 50, pp 7080-7086, issn 0264-410X, 7 p.Article

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicityGOMEZ-ROMAN, V. Raul; FLORESE, Ruth H; PATTERSON, L. Jean et al.Journal of immunological methods. 2006, Vol 308, Num 1-2, pp 53-67, issn 0022-1759, 15 p.Article

Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adultsDURIE, Christine; LAUNAY, Odile; MEIFFREDY, Vincent et al.AIDS (London). 2006, Vol 20, Num 7, pp 1039-1049, issn 0269-9370, 11 p.Article

Statistical evaluation of HIV vaccines in early clinical trialsMOODIE, Zoe; ROSSINI, A. J; HUDGENS, Michael G et al.Contemporary clinical trials. 2006, Vol 27, Num 2, pp 147-160, issn 1551-7144, 14 p.Article

Barriers to participating in an HIV vaccine trial: a systematic reviewMILLS, Edward; COOPER, Curtis; GUYATT, Gordon et al.AIDS (London). 2004, Vol 18, Num 17, pp 2235-2242, issn 0269-9370, 8 p.Article

The marginal willingness-to-pay for attributes of a hypothetical HIV vaccineCAMERON, Michael P; NEWMAN, Peter A; ROUNGPRAKHON, Surachet et al.Vaccine. 2013, Vol 31, Num 36, pp 3712-3717, issn 0264-410X, 6 p.Article

Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in AustraliaGRAY, Richard T; GHAUS, Mohammad H; HOARE, Alexander et al.Vaccine. 2011, Vol 29, Num 36, pp 6125-6129, issn 0264-410X, 5 p.Conference Paper